HEALTH TECHNOLOGY

IQVIA Decentralized Clinical Trial Program Achieves Independent GDPR Validation

IQVIA | September 29, 2022 | Read time : 02:00 min

IQVIA Decentralized

IQVIA a leading global provider of advanced analytics, technology solutions and contract services to the life sciences industry announced its Decentralized Clinical Trial (DCT) program has received GDPR compliance validation from TRUSTArc. This marks the first instance of a DCT service receiving this European data privacy validation.

TRUSTArc’s third-party validation demonstrates that IQVIA’s DCT program processes personal data in accordance with GDPR, allowing customers to address participant and investigator privacy concerns that may arise because of their participation in decentralized trials.

“At IQVIA, we are committed to delivering decentralized studies, we recognize the criticality of patient data protection in doing this and we understand the focus on data protection by European regulators,” said Ronan Brown, SVP and head of Patient Centric Solutions & Decentralized Trials. “IQVIA is proud to have this validation prove our longstanding dedication to data protection in decentralized trials.”

TRUSTArc maps it’s GDPR Validation requirements to applicable GDPR Articles and ISO 27001 standards, alongside the standards of it’s own Privacy and Data Governance Accountability Framework. This validation is yet another step IQVIA has taken to enable DCTs to be brought to a wider group of participants, improving diversity, sustainability, and trust in clinical development.

Achieving a GDPR validation demonstrates IQVIA’s commitment to ensuring the highest standards of delivering decentralized studies to the people it serves. Organizations of all sizes must become privacy-forward to earn the trust of their customers. IQVIA has consistently prioritized being privacy-forward to earn the trust of their customers and the TRUSTArc GDPR and CCPA Validations reinforce that standing.”

Chris Babel, CEO, TRUSTArc

About IQVIA
IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors, and scientific advances, in an effort to advance their path toward cures.

Spotlight

Autoimmune diseases affect millions of people across the globe. Scientists often don't know the precise cause of the disease, and diagnosing autoimmunity can be difficult. Even the immune system is prone to error, and autoimmunity and autoimmune diseases are the results of that mistake.

Spotlight

Autoimmune diseases affect millions of people across the globe. Scientists often don't know the precise cause of the disease, and diagnosing autoimmunity can be difficult. Even the immune system is prone to error, and autoimmunity and autoimmune diseases are the results of that mistake.

Related News

HEALTH TECHNOLOGY

MobileSmith Health Announces Go-Live at CHI St. Vincent Infirmary

MobileSmith | September 15, 2022

MobileSmith a leading provider of cutting-edge mobile software solutions, announces delivery and live status of their PeriOp solution at CHI St. Vincent Infirmary. MobileSmith Health is proud to partner with CHI St. Vincent in improving throughput and clinical care for surgical patients using the PeriOp solution. This toolset provides visibility of patient activities and status to the clinical team preparing to welcome patients for surgery. The adherence dashboard helps clinicians focus on the patients who need the most help. Patients, in turn, get education about their procedure, complete necessary preoperative tasks, and are better prepared to manage their care at home. "We are thrilled to partner with CHI St. Vincent and their innovative team. Our work addresses patient outcomes while improving patient satisfaction. It also reduces the workload of clinical staff by automating routine tasks and improving predictability in patient throughput," Chris Caramanico, Chief Executive Officer of MobileSmith Health "The MobileSmith Health team has been a pleasure to work with. We have a shared vision and passion to make healthcare communication to the patient reliable and more efficient. The combination of MobileSmith Health and our talented and innovative team at CHI St. Vincent are proving that we can make a difference in the daily work of many clinicians while improving patient outcomes," said Dr. Jill Flaxman, Medical Director of Perioperative Services. About MobileSmith MobileSmith Health is a digital health technology company focused on increasing efficiency and improving outcomes by providing clinicians with modern pre- and post-surgery dashboard, showing how patients participate in their own care. PeriOp, MobileSmith Health’s patient app, connects providers to their patients, streamlines information, simplifies surgery preparation and discharge and reduces complications. PeriOp by MobileSmith Health makes the science, process and oversight simple.

Read More

HEALTH TECHNOLOGY

Trukera™ Medical Launches New ScoutPro™ Osmolarity System

Trukera Medical | September 13, 2022

Trukera™ Medical last week announced a corporate rebranding to reflect thea company’s expanded vision and strategic growth plans targeting broader unmet needs in corneal health. Trukera Medical unveiled the first product under the new company name, the ScoutPro™ Osmolarity System. Designed to help advance corneal health decisions for today’s busy eye care practices, ScoutPro is the first and only portable osmometer in the U.S. “The ScoutPro Osmolarity System is an exciting technology developed around the evolving needs of today’s eye care professionals. Premium cataract and refractive practices are now the fastest growing adopters of osmolarity testing, given the prevalence of hyperosmolarity in their patient demographics and the risk it poses to compromising corneal cell health and driving refractive instability. More than ever, these practices require patient care solutions that can seamlessly adapt into established operational models, not the other way around, to deliver a premium patient experience, efficiency of care, and minimize staff time and disruptions. We’re proud to bring a solution to market addressing these needs, and to help more practices objectively identify and manage such a critical component to patient’s corneal health and refractive outcomes.” Adam Szaronos, Trukera Medical CEO The ScoutPro Osmolarity System brings together nanoliter volume sample collection and analysis in a single portable device. Users can now bring laboratory testing to patients anywhere in the practice to quickly test and provide objective results in the palm of their hand. The system is built upon the company’s established accuracy trusted in over 24 million tests globally to date, with an industry-leading precision. “Toxic hyperosmolarity damages sensitive corneal nerves and may cause refractive instability. As cornea and cataract/refractive specialists, we are cognizant of the importance of this to our surgical outcomes and the overall health of our patients’ eyes. ScoutPro gives us the ability to precisely determine osmolarity quickly and easily, without disrupting patient flow,” said Dr. Lisa Nijm, Chief Medical Advisor for Ophthalmology at Trukera Medical and Corneal Surgeon at Warrenville Eye Care and LASIK Center in Illinois. The ScoutPro Osmolarity System is now available for pre-order in the U.S. and will be commercially launched at the upcoming World Cornea Congress and the American Academy of Ophthalmology later this month. About Trukera Medical Trukera Medical is a global leader in developing and marketing comprehensive corneal health technologies. The company introduced tear osmolarity testing to eye care with its flagship device, the TearLab Osmolarity System, which has been used over 24 million times worldwide. Trukera Medical’s expanding portfolio includes ScoutPro, the first and only portable osmolarity system in the U.S. The company’s dedicated focus is improving corneal health, both as a primary goal and in preparation for surgery.

Read More

DIGITAL HEALTHCARE

Commure Introduces New Model to Accelerate Transformation in Healthcare with CommureOS

Commure | November 14, 2022

To help healthcare organizations hurdle long-standing barriers to meaningful transformation and drive exponential innovation at scale, Commure, Inc. today introduced CommureOS, a revolutionary transformation platform purpose-built for healthcare, at HLTH 2022. CommureOS is designed to give healthcare organizations the power to synthesize and maximize their existing solutions as well as easily build and rapidly deploy intelligent workflows to enhance clinical, operational, and financial efficiency. By reconciling information through a single platform and facilitating easy and connected innovation, CommureOS enables hospitals and health systems to streamline their technology experience, empower their healthcare workforce, and enhance care delivery and outcomes. “For decades, health organizations have been pushed to innovate at near-impossible speeds to keep up with the industry’s rate of change — and have made remarkable strides despite it all, More than ever, they deserve a robust tech experience that ensures their progress can endure. Over the past five years, we’ve been quietly and responsibly building a new model of innovation with some of our nation’s biggest health systems — and today, we invite pioneering organizations to embark with us on a new era of healthcare transformation.” -Ashwini Zenooz, MD, CEO of Commure With CommureOS, healthcare organizations can more effectively and efficiently: Unlock and connect disparate data points and static insights across their technology ecosystem and make them actionable and helpful at the point of care. Create, test, and deploy new solutions to solve their unique challenges with modular and industry-native building blocks — turning months of development into hours of configuration. Reuse established clinical and non-clinical data connections and extend across multiple use cases and workflows to seamlessly scale innovation throughout their organization. At a time when hospitals and health systems across the country are grappling with rising burnout and attrition, Commure is steadfast in our commitment to empower the healthcare workforce by simplifying and optimizing the tasks they do and the workflows they use every day, By helping health organizations derive meaning from mountains of data and build connected solutions at scale, we can finally ensure that people — rather than technology — are at the heart of our healthcare ecosystem,said Abhijit Mitra, chief product and engineering officer at Commure. With CommureOS, leading health systems and hospitals have the tools and support to create or customize the organizational workflows they need with ease, enabling them to streamline traditionally manual and time-consuming tasks and cultivate a more dynamic experience for clinicians, staff, and care delivery teams. There’s a new generation of digital health innovators keeping health systems at the center of their own transformation journeys — and Commure is at the forefront, Migrating from point solutions to platform is essential for technology-driven transformation of the sector. By connecting the dots and driving exceptional experiences, Commure is advancing our collective pursuit of responsible and enduring innovation,said Hemant Taneja, CEO and managing director at General Catalyst and co-founder of Commure. About Commure Commure, Inc. is building the first operating system designed for healthcare. By connecting disparate datasets, surfacing meaningful insights, accelerating performance through a suite of intuitive applications, and enabling seamless innovation across the industry, we empower every person in the health ecosystem to deliver exceptional care. Commure’s original applications include solutions to improve staff safety, enhance clinical workflow, and bolster financial operations. Commure is partnering with health systems, payors, and digital innovators to build a vibrant health ecosystem together; currently, the company enables more than 160,000 clinicians and staff across more than 400 care facilities to advance care through collaboration.

Read More